Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Alcohol (Fayetteville, N.Y.)|July 17, 2007
Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activationNorio Horiguchi, Edward J N Ishac, Bin GaoFrontiers in Physiology|April 12, 2012
Cytokines and STATs in Liver FibrosisXiaoni Kong, Norio Horiguchi, Masatomo Mori, et al.Anticancer Research|March 14, 2013
Hepatocyte growth factor promotes lung carcinogenesis in transgenic mice treated with diethylnitrosamineAkira Kojima, Norio Horiguchi, Satoru Kakizaki, et al.Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver diseaseSatoru Kakizaki, Daichi Takizawa, Hiroki Tojima, et al.World Journal of Gastroenterology|November 8, 2005
Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicityYuichi Yamazaki, Satoru Kakizaki, Norio Horiguchi, et al.Carcinogenesis|December 22, 2010
Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitisDaichi Takizawa, Satoru Kakizaki, Norio Horiguchi, et al.Alcoholism, Clinical and Experimental Research|February 3, 2011
Molecular mechanisms of alcoholic liver disease: innate immunity and cytokinesAndrew M Miller, Norio Horiguchi, Won-Il Jeong, et al.Acta Medica Okayama|February 27, 2013
A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohortsHiroaki Hashizume, Ken Sato, Yuichi Yamazaki, et al.World Journal of Hepatology|December 22, 2010
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis CHideyuki Suzuki, Satoru Kakizaki, Norio Horiguchi, et al.World Journal of Gastroenterology|September 17, 2013
Extended therapy duration for therapy-refractory hepatitis C patients with genotype 2Ken Sato, Masatoshi Yanagisawa, Hiroaki Hashizume, et al.Pageof 7